Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

A handheld dermatoscope helps diagnose different types of hair loss effectively.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.